Benefits
Supplies Selenium for Antioxidant Enzymes
Selenocystine can be metabolized to release selenium that feeds glutathione peroxidase and other selenoproteins. In animal models it raises tissue selenium and supports antioxidant enzyme activity, contributing to the body's defense against oxidative stress.
Bioavailable Selenium Source
As a selenoamino-acid compound, selenocystine is absorbed and used to build selenoproteins. Feeding studies show it can restore glutathione peroxidase activity in selenium-deficient animals comparably to other selenium forms.
Antioxidant Redox Activity
The diselenide bond in selenocystine participates in redox chemistry that can mimic glutathione peroxidase-like peroxide scavenging in laboratory systems. This underlies interest in selenocystine as an antioxidant-relevant selenium compound.
General Selenium Status Support
Like other selenium sources, selenocystine contributes elemental selenium that helps maintain the selenoproteins involved in antioxidant defense, thyroid metabolism, and immune function once it is metabolized in the body.
Mechanism of action
Reduction to Selenocysteine
Selenocystine is reduced by cellular thiol systems to two molecules of selenocysteine, the bioactive selenoamino acid, which can then be channeled into selenium metabolism rather than directly inserted into proteins.
Selenocysteine Lyase Catabolism
Free selenocysteine derived from selenocystine is broken down by selenocysteine lyase to release selenide, the common intermediate that is reused for de novo selenoprotein synthesis rather than incorporated intact.
Selenoprotein Synthesis
Selenide generated from selenocystine is converted to selenophosphate and co-translationally inserted as selenocysteine into glutathione peroxidases and thioredoxin reductases, supporting their antioxidant and redox-regulating functions.
Glutathione Peroxidase-Like Redox Cycling
In vitro, the diselenide of selenocystine can cycle between oxidized and reduced states to decompose hydroperoxides, a chemical antioxidant behavior that is distinct from its nutritional role as a selenium donor.
Clinical trials
Controlled animal feeding study comparing dietary selenite, selenocystine, and selenomethionine in weanling rats, assessing tissue selenium levels, glutathione peroxidase activity, and selenocysteine lyase activity over 9 weeks.
Weanling male rats; preclinical, not a human trial.
All three selenium forms, including selenocystine, restored glutathione peroxidase activity in selenium-deficient rats with no significant differences between forms, and tissue selenium rose with supplementation. The study documents selenocystine as a usable selenium source but provides only animal-level evidence.
High-dose human supplementation trial comparing selenomethionine, sodium selenite, and high-selenium yeast on plasma selenium and selenoprotein markers; included as context because selenocystine itself lacks comparable standalone human trials.
Selenium-replete adults; selenocystine not directly tested.
The trial characterized how different selenium forms affect glutathione peroxidase and selenoprotein P in humans, but selenocystine was not among the tested forms. It is cited to illustrate the human evidence gap: selenocystine's effects in people are inferred from animal data rather than direct human supplementation trials.